Virtu Financial’s Apellis Pharmaceuticals APLS Stock Holding History

Virtu Financial’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-54,785	Closed	-$2.2M	–	1578
2026 Q1	$2.2M	Buy	+54,785	New	+$1.18M	0.09%	140
2025 Q1	–	Sell	-7,157	Closed	-$228K	–	1326
2024 Q4	$228K	Sell	7,157 -6,369	-47%	-$192K	0.01%	822
2024 Q3	$390K	Buy	+13,526	New	+$501K	0.02%	536
2023 Q4	–	Sell	-23,235	Closed	-$884K	–	1543
2023 Q3	$884K	Buy	+23,235	New	+$1.02M	0.09%	204
2021 Q3	–	Sell	-4,339	Closed	-$274K	–	1469
2021 Q2	$274K	Buy	+4,339	New	+$224K	0.03%	780

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Virtu Financial's APLS Position: Q2 2026 in Review

Virtu Financial sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 54,785 shares — an estimated $2.2M sold.

Virtu Financial first reported a position in APLS in Q2 2021 and held it in 5 quarters. The position peaked at $2.2M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Virtu Financial reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Virtu Financial sold 54,785 Apellis Pharmaceuticals shares in Q2 2026, an estimated $2.2M.
Virtu Financial first reported a position in Apellis Pharmaceuticals in Q2 2021 and held it in 5 quarters.
Virtu Financial's Apellis Pharmaceuticals position peaked at $2.2M in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.